Fund Holdings — Avoro Capital Advisors LLC

Total Portfolio Value:
$11.14B
Total Bought:
$2.63B
Total Sold:
$2.74B
Net Transaction:
-$116.55M
Notable People:
Behzad Aghazadeh, Avoro Capital L.P.
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)2,630,0002,777,777+147,777$1.56B$1.51B13.52%-$54.45M
Ascendis Pharma A/S(ASND)05,111,111+5,111,111$0$1.36B12.24%+$1.36B
Krystal Biotech, Inc.(KRYS)2,888,8882,888,8880$746.26M$1.07B9.64%+$327.46M
Madrigal Pharmaceuticals, Inc.(MDGL)1,818,1811,833,333+15,152$951.76M$984.41M8.84%+$32.64M
argenx SEADR(ARGX)1,000,0001,000,0000$730.25M$927.77M8.33%+$197.52M
Arrowhead Pharmaceuticals, Inc.(ARWR)10,699,99911,355,555+655,556$670.89M$925.59M8.31%+$254.70M
Kymera Therapeutics, Inc.(KYMR)7,474,7477,474,7470$622.57M$857.13M7.70%+$234.56M
Revolution Medicines, Inc.(RVMD)2,344,4442,297,000-47,444$228.00M$430.18M3.86%+$202.18M
Cytokinetics, Incorporated(CYTK)3,333,3334,999,999+1,666,666$219.70M$425.95M3.82%+$206.25M
Celcuity Inc.(CELC)3,375,0003,400,000+25,000$385.22M$355.71M3.19%-$29.51M
Structure Therapeutics IncADS6,555,5556,555,5550$315.98M$351.84M3.16%+$35.86M
Xenon Pharmaceuticals Inc.(XENE)5,777,7775,777,7770$335.98M$348.75M3.13%+$12.77M
Definium Therapeutics, Inc.(DFTX)5,000,0007,188,888+2,188,888$94.50M$338.17M3.04%+$243.67M
uniQure N.V.(QURE)5,959,5956,727,777+768,182$97.44M$309.88M2.78%+$212.44M
Vera Therapeutics, Inc.(VERA)5,888,8885,723,888-165,000$236.91M$245.61M2.21%+$8.70M
Taysha Gene Therapies, Inc.(TSHA)21,700,00023,888,888+2,188,888$97.00M$162.68M1.46%+$65.68M
Ocular Therapeutix, Inc.(OCUL)12,315,00012,540,000+225,000$104.31M$123.14M1.11%+$18.83M
Damora Therapeutics, Inc.(DMRA)3,783,0003,783,0000$97.98M$98.40M0.88%+$416.1K
Hemab Therapeutics Hldgs Inc01,925,150+1,925,150$0$70.71M0.63%+$70.71M
GH Research PLC(GHRS)1,800,0001,800,0000$25.31M$48.38M0.43%+$23.08M
Viridian Therapeutics, Inc.(VRDN)1,500,0002,500,000+1,000,000$29.34M$45.92M0.41%+$16.59M
Septerna, Inc.(SEPN)1,337,5001,337,5000$32.14M$44.79M0.40%+$12.65M
Avalo Therapeutics, Inc.(AVTX)1,410,0002,333,333+923,333$21.05M$43.12M0.39%+$22.07M
Faeth Therapeutics, Inc.(FTH)01,444,039+1,444,039$0$36.10M0.32%+$36.10M
Whitehawk Therapeutics, Inc.(WHWK)2,849,4022,849,4020$9.83M$13.05M0.12%+$3.22M
Lexeo Therapeutics, Inc.(LXEO)1,875,0001,489,189-385,811$10.76M$6.93M0.06%-$3.83M
Alkermes plc(ALKS)1,200,0000-1,200,000$42.43M$0—-$42.43M
Apellis Pharmaceuticals Inc
COM
12,222,2220-12,222,222$491.70M$0—-$491.70M
Ascendis Pharma A/SADR(ASND)5,062,5000-5,062,500$1.16B$0—-$1.16B
Centessa Pharmaceuticals PlcADS11,430,4550-11,430,455$454.02M$0—-$454.02M
MannKind Corporation(MNKD)2,200,0000-2,200,000$5.39M$0—-$5.39M
Soleno Therapeutics Inc2,300,0000-2,300,000$77.00M$0—-$77.00M
Terns Pharmaceuticals Inc5,695,0000-5,695,000$300.24M$0—-$300.24M
Page 1 of 1
Avoro Capital Advisors LLC — 13F Holdings — Q2 2026 | TickerTrail